On Saturday, in a statement issued by IIT Kharagpur, it said that the researchers at the institute have developed a microneedle which can be used to administer large drug molecules painlessly.
Not only the diameter size of the microneedles is reduced but also the strength has been increased so that it does not break while penetrating the skin by the Department of Electrical Communication Engineering and the Department of Electronics at IIT Kharagpur. The statement said that the microneedle can be used even in COVID-19 vaccination in the future apart from insulin delivery.
Lead researcher Prof Tarun Kanti Bhattacharya said that a typical use could be achieved in insulin delivery or medication for the skin, diseases of the lymphatic system, including some forms of cancer, or even the vaccination for coronavirus.
He said that they have fabricated high strength glass carbon microneedles that can withstand the resistive forces of the skin. The designing of the ionic polymer-metal composite membrane based micropump is added that increases the flow rate of the drug molecules in a precise and controlled manner. They have also integrated the micropump and microneedle to achieve controlled drug delivery. The device will find extensive use in any form of intravenous medicine, he said.
He added that the more they engage in multidisciplinary R&D, the better they will be able to produce customized microneedle based effective delivery systems. The potential to transform the drug delivery system from the current syringe based to and effective and painless experience for the patients. As per medical protocol, the drug delivery system has been successfully tested with animals.
The research has been published by the researchers at IIT Kharagpur in Nature and JEE journals and the researchers have also filed for a patent in India. The statement added that the research for this innovation was funded by the Department of Science and Technology of Government of India and the Ministry of Electronics and Information Technology (MEITY).